Co-Diagnostics Past Earnings Performance
Past criteria checks 0/6
Co-Diagnostics's earnings have been declining at an average annual rate of -44.7%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been declining at an average rate of 14.8% per year.
Key information
-44.7%
Earnings growth rate
-42.2%
EPS growth rate
Medical Equipment Industry Growth | 4.3% |
Revenue growth rate | -14.8% |
Return on equity | -64.7% |
Net Margin | -563.9% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Co-Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 7 | -41 | 20 | 22 |
30 Jun 24 | 9 | -38 | 20 | 23 |
31 Mar 24 | 7 | -39 | 21 | 24 |
31 Dec 23 | 7 | -35 | 21 | 23 |
30 Sep 23 | 5 | -43 | 22 | 22 |
30 Jun 23 | 7 | -38 | 22 | 21 |
31 Mar 23 | 12 | -32 | 21 | 19 |
31 Dec 22 | 34 | -14 | 22 | 17 |
30 Sep 22 | 53 | 15 | 20 | 15 |
30 Jun 22 | 78 | 28 | 22 | 16 |
31 Mar 22 | 101 | 40 | 26 | 17 |
31 Dec 21 | 98 | 37 | 25 | 15 |
30 Sep 21 | 105 | 42 | 25 | 14 |
30 Jun 21 | 96 | 46 | 21 | 9 |
31 Mar 21 | 93 | 51 | 15 | 5 |
31 Dec 20 | 75 | 42 | 13 | 3 |
30 Sep 20 | 48 | 28 | 9 | 2 |
30 Jun 20 | 26 | 10 | 7 | 2 |
31 Mar 20 | 2 | -6 | 5 | 1 |
31 Dec 19 | 0 | -6 | 5 | 1 |
30 Sep 19 | 0 | -6 | 5 | 1 |
30 Jun 19 | 0 | -6 | 5 | 1 |
31 Mar 19 | 0 | -6 | 5 | 1 |
31 Dec 18 | 0 | -6 | 5 | 1 |
30 Sep 18 | 0 | -6 | 5 | 1 |
30 Jun 18 | 0 | -8 | 5 | 1 |
31 Mar 18 | 0 | -8 | 4 | 1 |
31 Dec 17 | 0 | -7 | 4 | 1 |
30 Sep 17 | 0 | -6 | 3 | 1 |
30 Jun 17 | 0 | -3 | 1 | 1 |
31 Mar 17 | 0 | -2 | 1 | 1 |
31 Dec 16 | 0 | -2 | 1 | 1 |
30 Sep 16 | 0 | -2 | 1 | 1 |
31 Dec 15 | 0 | -2 | 1 | 1 |
Quality Earnings: C97 is currently unprofitable.
Growing Profit Margin: C97 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: C97 is unprofitable, and losses have increased over the past 5 years at a rate of 44.7% per year.
Accelerating Growth: Unable to compare C97's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: C97 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Return on Equity
High ROE: C97 has a negative Return on Equity (-64.73%), as it is currently unprofitable.